peptide clinical trial
3 articles tagged with ‘peptide clinical trial’
Peptide Clinical Trial Research: A Practical Guide for Scientists
Research peptides are essential tools in biochemistry, cell biology, and molecular research. This guide covers the fundamentals of peptide science, synthesis, purification, quality control, and stability, providing laboratory scientists with practical guidance for working with research-grade peptides in in vitro and ex vivo applications.
NY-ESO-1 Peptide Clinical Trial: A Research Guide to Cancer/Testis Antigens
NY-ESO-1 (cancer/testis antigen 1B) is one of the most immunogenic proteins known and a central target in peptide-based cancer immunotherapy clinical trials. This article explains the biology of NY-ESO-1, key epitope clusters used in research, and how researchers can validate peptide tools for TCR-T cell therapy, cancer vaccines, and immune monitoring.
Peptide Clinical Trial: How a Synthetic LMP-1 Peptide Revealed EBV Lymphoma Mechanisms
A peptide clinical trial using a synthetic LMP-1 peptide helped researchers at the Medical University of Vienna decode how Epstein-Barr virus (EBV) drives Hodgkin's and non-Hodgkin's lymphomas. The study, published in Frontiers in Immunology, showed that a specific high-affinity LMP-1 peptide variant triggers immune escape via HLA-E signaling, inhibiting natural killer (NK) cells. This article breaks down the findings, explains the role of synthetic peptides in research, and points to Volta Peptides resources for verifying peptide quality.